应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LONA LeonaBio Inc
盘后交易 05-28 19:59:34 EDT
9.64
-0.17
-1.73%
盘后
9.83
+0.19
+1.97%
19:12 EDT
最高
10.02
最低
9.64
成交量
5,240
今开
10.02
昨收
9.81
日振幅
3.87%
总市值
9,055万
流通市值
2,476万
总股本
939.35万
成交额
5.21万
换手率
0.20%
流通股本
256.85万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
LeonaBio Inc预计Lasofoxifene三期试验患者招募将于2026年第四季度完成,关键数据将于2027年下半年公布
美股速递 · 03-27
LeonaBio Inc预计Lasofoxifene三期试验患者招募将于2026年第四季度完成,关键数据将于2027年下半年公布
Athira Pharma公司普通股将于1月12日以新交易代码在纳斯达克资本市场开始交易
美股速递 · 01-09
Athira Pharma公司普通股将于1月12日以新交易代码在纳斯达克资本市场开始交易
加载更多
公司概况
公司名称:
LeonaBio Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。
发行价格:
--
{"stockData":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":9.64,"timestamp":1779998400000,"preClose":9.81,"halted":0,"volume":5240,"hourTrading":{"tag":"盘后","latestPrice":9.83,"preClose":9.64,"latestTime":"19:12 EDT","volume":342,"amount":3297.486708,"timestamp":1780009962422,"change":0.19,"changeRate":0.01971,"amplitude":0.01971},"delay":0,"changeRate":-0.017329255861365946,"floatShares":2568500,"shares":9393514,"eps":-24.09,"marketStatus":"盘后交易","change":-0.17,"latestTime":"05-28 19:59:34 EDT","open":10.02,"high":10.02,"low":9.64,"amount":52147.98744,"amplitude":0.038736,"askPrice":9.93,"askSize":1,"bidPrice":8.81,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-24.09,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780012800000},"marketStatusCode":4,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":9.81,"preHourTrading":{"tag":"盘前","latestPrice":10.2,"preClose":9.81,"latestTime":"09:29 EDT","volume":10,"amount":102.09,"timestamp":1779974970022,"change":0.39,"changeRate":0.039755,"amplitude":0.001019},"postHourTrading":{"tag":"盘后","latestPrice":9.83,"preClose":9.64,"latestTime":"19:12 EDT","volume":342,"amount":3297.486708,"timestamp":1780009962422,"change":0.19,"changeRate":0.01971,"amplitude":0.01971},"volumeRatio":0.069145},"requestUrl":"/m/hq/s/LONA","defaultTab":"news","newsList":[{"id":"1124104746","title":"LeonaBio Inc预计Lasofoxifene三期试验患者招募将于2026年第四季度完成,关键数据将于2027年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1124104746","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124104746?lang=zh_cn&edition=full","pubTime":"2026-03-27 05:13","pubTimestamp":1774559590,"startTime":"0","endTime":"0","summary":"LeonaBio Inc宣布,其针对Lasofoxifene的三期临床试验预计将在2026年第四季度完成患者招募工作。该试验的关键数据结果计划于2027年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LONA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121680450","title":"Athira Pharma公司普通股将于1月12日以新交易代码在纳斯达克资本市场开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1121680450","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121680450?lang=zh_cn&edition=full","pubTime":"2026-01-09 20:04","pubTimestamp":1767960259,"startTime":"0","endTime":"0","summary":"Athira Pharma, Inc. 已确认,其普通股将于1月12日(周五)在纳斯达克资本市场开始交易,并将采用新的股票交易代码。\n此次交易代码的变更标志着公司发展的一个新阶段,预计将为市场参与者和投资者提供更清晰的公司标识。股票交易的相关具体信息,投资者可关注官方公告或交易所发布的通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ATHA","LONA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leonabio.com","stockEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.1749},{"period":"3month","weight":0.7456},{"period":"6month","weight":1.2552},{"period":"1year","weight":2.4181},{"period":"ytd","weight":0.2959}],"compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":0.0493},{"period":"3month","weight":0.0887},{"period":"6month","weight":0.0981},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.081093},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02158},{"month":3,"riseRate":0.333333,"avgChangeRate":0.058482},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.076601},{"month":5,"riseRate":0.666667,"avgChangeRate":0.067692},{"month":6,"riseRate":0.4,"avgChangeRate":-0.221545},{"month":7,"riseRate":0.6,"avgChangeRate":0.106269},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034355},{"month":9,"riseRate":0.2,"avgChangeRate":-0.224006},{"month":10,"riseRate":0.5,"avgChangeRate":0.036994},{"month":11,"riseRate":0.666667,"avgChangeRate":0.141696},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280766}],"exchange":"NASDAQ","name":"LeonaBio Inc","nameEN":"LeonaBio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LeonaBio Inc(LONA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LeonaBio Inc(LONA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LeonaBio Inc,LONA,LeonaBio Inc股票,LeonaBio Inc股票老虎,LeonaBio Inc股票老虎国际,LeonaBio Inc行情,LeonaBio Inc股票行情,LeonaBio Inc股价,LeonaBio Inc股市,LeonaBio Inc股票价格,LeonaBio Inc股票交易,LeonaBio Inc股票购买,LeonaBio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LeonaBio Inc(LONA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LeonaBio Inc(LONA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}